BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7689246)

  • 1. In vitro thermal enhancement of human T-cell leukaemia/lymphoma virus type I (HTLV-I) in HTLV-I-transformed cells.
    Sun D; Archibald DW; Sauk JJ
    Res Virol; 1993; 144(3):185-91. PubMed ID: 7689246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced human T-cell lymphotropic virus type I expression following induction of the cellular stress response.
    Andrews JM; Oglesbee MJ; Trevino AV; Guyot DJ; Newbound GC; Lairmore MD
    Virology; 1995 Apr; 208(2):816-20. PubMed ID: 7747457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease of heat shock protein 27/28 with heat stress in HTLV-I-transformed cells.
    Sun D; Sauk JJ; Archibald DW
    Exp Mol Pathol; 1994 Jun; 60(3):147-57. PubMed ID: 7957775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling via the CD2 receptor enhances HTLV-1 replication in T lymphocytes.
    Guyot DJ; Newbound GC; Lairmore MD
    Virology; 1997 Jul; 234(1):123-9. PubMed ID: 9234953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure of p19 matrix protein of human T-cell leukemia virus type I (HTLV-I) on the surface of MOLT-4#8 cells after virus adsorption.
    Akari H; Kuroda MJ; Shinjo T; el-Farrash MA; Harada S
    Arch Virol; 1994; 136(3-4):389-95. PubMed ID: 8031242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small noncoding RNAs in cells transformed by human T-cell leukemia virus type 1: a role for a tRNA fragment as a primer for reverse transcriptase.
    Ruggero K; Guffanti A; Corradin A; Sharma VK; De Bellis G; Corti G; Grassi A; Zanovello P; Bronte V; Ciminale V; D'Agostino DM
    J Virol; 2014 Apr; 88(7):3612-22. PubMed ID: 24403582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgM secreted by human T lymphoma virus-I-infected and transformed human B cell clones recognize a 66-kilodalton host-encoded protein.
    Ng VL; Rainer C; Oliver MR; Marsh J; Wood P; Reyes GR; McGrath MS
    J Immunol; 1989 Oct; 143(8):2501-7. PubMed ID: 2477445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection of human T-lymphotropic virus type-I (HTLV-I)-bearing MT-4 cells with HTLV-III (AIDS virus): chronological studies of early events.
    Harada S; Koyanagi Y; Yamamoto N
    Virology; 1985 Oct; 146(2):272-81. PubMed ID: 2413616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AZT inhibits the transmission of human T cell leukaemia/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro.
    Macchi B; Faraoni I; Zhang J; Grelli S; Favalli C; Mastino A; Bonmassar E
    J Gen Virol; 1997 May; 78 ( Pt 5)():1007-16. PubMed ID: 9152417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic nucleotide phosphodiesterases (PDE) 3 and 4 in normal, malignant, and HTLV-I transformed human lymphocytes.
    Ekholm D; Mulloy JC; Gao G; Degerman E; Franchini G; Manganiello VC
    Biochem Pharmacol; 1999 Sep; 58(6):935-50. PubMed ID: 10509746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of HIV-1 replication and intracellular accumulation of particles in HTLV-I-transformed cells.
    Kiernan R; Marshall J; Bowers R; Doherty R; McPhee D
    AIDS Res Hum Retroviruses; 1990 Jun; 6(6):743-52. PubMed ID: 2364017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superoxide-Generating Nox5α Is Functionally Required for the Human T-Cell Leukemia Virus Type 1-Induced Cell Transformation Phenotype.
    Shigemura T; Shiohara M; Kato M; Furuta S; Kaneda K; Morishita K; Hasegawa H; Fujii M; Gorlach A; Koike K; Kamata T
    J Virol; 2015 Sep; 89(17):9080-9. PubMed ID: 26109726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two types of HTLV-1 particles are released from MT-2 cells.
    Morozov VA; Weiss RA
    Virology; 1999 Mar; 255(2):279-84. PubMed ID: 10069953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T-cell lymphotropic virus type 1 can infect primary rat retinal glial cells and induce gene expression of inflammatory cytokines.
    Sato Y; Ito K; Moritoyo T; Fujino Y; Masuda K; Yamaguchi K; Mochizuki M; Izumo S; Osame M; Watanabe T
    Curr Eye Res; 1997 Aug; 16(8):782-91. PubMed ID: 9255507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmission of human T-cell leukemia virus type I from a patient with HTLV-I associated myelopathy/tropical spastic paraparesis and an asymptomatic carrier to rabbits.
    Minagawa H; Mora CA; Asher DM; Stone GA; Liberski PP; Gibbs CJ
    Arch Virol; 1991; 118(3-4):235-45. PubMed ID: 1712582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of inhibitory effect of dextran sulfate and heparin on human T-cell lymphotropic virus type I (HTLV-I)-induced syncytium formation in vitro: role of cell-to-cell contact.
    Ida H; Kurata A; Eguchi K; Yamashita I; Nakashima M; Sakai M; Kawabe Y; Nakamura T; Nagataki S
    Antiviral Res; 1994 Feb; 23(2):143-59. PubMed ID: 7908510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I.
    De Rossi A; Franchini G; Aldovini A; Del Mistro A; Chieco-Bianchi L; Gallo RC; Wong-Staal F
    Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4297-301. PubMed ID: 2424024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrastructural localization of HTLV-I gag proteins p19 and p24 by single and double immunogold labeling.
    Stransky G; Gay S
    J Histochem Cytochem; 1991 Feb; 39(2):185-91. PubMed ID: 1987262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative anti-viral and anti-proliferative activity of PGA1 and PGJ2 against HTLV-I-infected MT-2 cells.
    D'Onofrio C; Amici C; Puglianiello A; Faraoni I; Lanzilli G; Santoro MG; Bonmassar E
    Int J Cancer; 1992 May; 51(3):481-8. PubMed ID: 1592539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the tax-dependent human T-lymphotropic virus type I replication in persistently infected cells by the fluoroquinolone derivative k-37.
    Wang X; Miyake H; Okamoto M; Saito M; Fujisawa J; Tanaka Y; Izumo S; Baba M
    Mol Pharmacol; 2002 Jun; 61(6):1359-65. PubMed ID: 12021397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.